Obido, Al-nadjer .
HRN: 27-43-22 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/05/2026
04/11/2026
IV
260mg
Q6
PCAP C
Checking Initial Appropriateness
04/07/2026
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
04/07/2026
04/14/2026
PO
2.5mL
BID
PCAP;UTI
Checking Initial Appropriateness